Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients
Julie De Smedt,Claudia Aura,Sofie Van Kelst,Laudine Janssen,Vivien Marasigan,Veerle Boecxstaens,Marguerite Stas,Kris Bogaerts,Ann Belmans,Isabelle Cleynen,Dirk Vanderschueren,Katleen Vandenberghe,Oliver Bechter,Arjen Nikkels,Tinne Strobbe,Gabriella Emri,Dieter Lambrechts,Marjan Garmyn
DOI: https://doi.org/10.1097/cmr.0000000000000929
2024-03-04
Melanoma Research
Abstract:Cutaneous melanoma (CM) is the number one cause of death from skin cancer, with rising incidence rates worldwide during past decades. CM caused in 2020, an estimated 3.6 mortality rate (European age-standardized per 100 000) for both sexes in Belgium [ 1 ]. Melanoma pathogenesis implicates a stepwise transformation of melanocytes to melanoma, with subsequent superficial and deep invasion and metastasis. The strongest risk factors are a family history of CM, multiple benign or atypical naevi, and a previous CM. Additional risk factors are use of immunosuppression, fair phototype and exposure to ultraviolet light (UV). Melanoma is classified into melanoma in situ, confined to the epidermis, or invasive melanoma, with invasion into the dermis. UV exposure through sun exposure and tanning beds is a well-known risk factor for CM. On the other hand, UV radiation is the main source of vitamin D (VD) synthesis. The latter exists in two forms, vitamin D2 (VD2) and vitamin D3 (VD3). VD2 is the plant-derived form and is exclusively obtained through the diet. VD3 can be produced in the skin from 7-dehydrocholesterol after exposure to a sufficient amount of UVB or obtained from dietary sources. In the classical metabolic pathway, VD is consecutively metabolized by the liver and kidneys to the active form 1alpha,25-dihydroxyvitamin D (1,25OHD). Other pathways in the human body for the production of 1,25OHD are described [ 2 ]. VD acts through activation of the vitamin D receptor (VDR). Measurement of the serum concentration of 25-hydroxyvitamin D (25OHD) is the gold standard for assessing the VD status in the body [ 3 ]. The role of VD is controversial: contrary to the negative effects of UV radiation on melanoma pathogenesis, evidence suggest that VD plays a beneficial role in several malignancies, including CM. Laboratory data, animal studies, epidemiological observations and clinical studies indicate that VD may affect tumor progression or CM outcome. Several epidemiological studies suggested a better prognosis for CM patients with normal serum VD levels at diagnosis compared to CM patients with low serum VD levels [ 4 ]. Higher VD levels are associated with lower Breslow thickness and a better overall survival and progression-free survival [ 5 ]. VD exerts its physiological function via the VDR, a nuclear transcription factor belonging to the nuclear receptor superfamily that binds 1,25OHD with high affinity and specificity. Upon binding to 1,25OHD and coreceptor protein retinoid X receptor, VDR translocate from cytoplasm into the nucleus and binds to vitamin D responsive elements (VDREs), which up- or down-regulate hundreds of genes directly controlled by VD. The human VDR gene is located on chromosome 12q13.11 and comprises at least 5 promotor regions, 11 exons and 11 introns [ 6 ].
dermatology,oncology,medicine, research & experimental